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background:  Electrical cardioversion (EC) is one of the most effective treatment modalities in restoration of sinus rhythm (SR) in atrial 
fibrillation (AF) patients. Atrial structural remodeling has been suggested to contribute to AF recurrence following EC. Role of several 
inflammatory and extracellular matrix turnover markers on AF recurrence following EC has been investigated. However, there is paucity of 
data on the impact of Galectin-3 (Gal-3), which is known to play an important role in various fibrotic conditions, including cardiac fibrosis. In 
this study, we aimed to demonstrate the predictive role of serum Gal-3 levels in AF recurrence following successful EC.
Methods:  We prospectively enrolled 65 persistent AF patients who were scheduled for EC. Serum samples were assayed for pre-EC Gal-
3 levels by ELISA. Patients were followed- up for 3 months.
results:  65 AF patients (56.09± 8.03 years; 46.15% male gender) were involved. Despite initial 100% cardioversion to sinus rhythm, 28 
(43.08%) suffered AF relapse within 3 months. In multivariate analysis, LAD (HR: 3.995, p=0.001) and serum Gal-3 levels (HR: 1.447, 
p<0.001) were found to be independent predictors of AF recurrence following successful EC. Patients with serum Gal-3 levels of ≥7.05 ng/
mL had higher recurrence rate in the third month following EC (p<0.001) (Figure 1).
Conclusion:  Gal-3 may have a role in prediction of success following EC. Impact of Gal-3 in atrial structural remodeling may be the cause 
of perpetuation and recurrence of AF.
 
